1-4 of 4
Xia V. Yang, PhD
Close
Sort by
Journal Articles

Activation of the PI3K-Akt Pathway by Activated Protein C Occurs Via a Novel Receptor, Apolipoprotein E Receptor 2 (ApoER2)

Xia V. Yang, PhD, Yajnavalka Banerjee, PhD, Jose A. Fernandez, MD, PhD, Hiroshi Deguchi, MD, PhD, Xiao Xu, Laurent O. Mosnier, PhD, Rolf T Urbanus, MD, Phillip G deGroot, PhD, Tara C White, Owen J.T. McCarty, PhD, John H. Griffin, PhD
Journal: Blood
Blood (2008) 112 (11): 695.
https://doi.org/10.1182/blood.V112.11.695.695
Published: 2008
Journal Articles

In Vivo Anti-Thrombotic Potency of Engineered Activated Protein C Variants.

Laurent O. Mosnier, PhD, Jose A. Fernandez, MD/PhD, Antonella Zampolli, PhD, Xia V. Yang, PhD, Zaverio M. Ruggeri, MD, John H. Griffin, PhD
Journal: Blood
Blood (2007) 110 (11): 2704.
https://doi.org/10.1182/blood.V110.11.2704.2704
Published: 2007
Journal Articles

Preservation of Beneficial TAFI Functions by an Activated Protein C Variant with Normal Cytoprotective Functions but Minimal Anticoagulant Activity.

Laurent O. Mosnier, PhD, Xia V. Yang, PhD, John H. Griffin, PhD
Journal: Blood
Blood (2007) 110 (11): 268.
https://doi.org/10.1182/blood.V110.11.268.268
Published: 2007
Journal Articles

Anti-Inflammatory and Anti-Apoptotic Activities of Activated Protein C Are Independent of Anticoagulant Activity.

Xia V. Yang, PhD, John H. Griffin, PhD, Laurent O. Mosnier, PhD
Journal: Blood
Blood (2006) 108 (11): 65.
https://doi.org/10.1182/blood.V108.11.65.65
Published: 2006